api

Sanofi set to spin off API business late next year – report

https://pharmaphorum.com/news/sanofi-set-to-spin-off-api-business-late-next-year-report/

Trump’s boasting overshadows supply deal for COVID-19 drugs

https://pharmaphorum.com/news/hopped-up-on-hydroxychloroquine-trump-signs-354m-deal-for-covid-19-drug-supply/

The COVID-19 coronavirus and pharma and biotech continuity planning

https://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/

Sanofi to combat shortages with European medicines ingredient firm

https://pharmaphorum.com/news/sanofi-to-combat-shortages-with-european-medicines-ingredient-firm/

Highly Potent Active Pharmaceutical Ingredients Conference – Under 1 Week Left!

https://pharmaphorum.com/partner-content/highly-potent-active-pharmaceutical-ingredients-conference-under-1-week-left/

Highly Potent Active Pharmaceutical Ingredients – Under 2 Weeks Remain!

https://pharmaphorum.com/partner-content/highly-potent-active-pharmaceutical-ingredients-under-2-weeks-remain/

Highly Potent Active Pharmaceutical Ingredients Conference Hosts 2 Interactive Workshops

https://pharmaphorum.com/partner-content/highly-potent-active-pharmaceutical-ingredients-conference-hosts-2-interactive-workshops/

Exclusive Interview Released with HPAPI Project Services

https://pharmaphorum.com/partner-content/exclusive-interview-released-with-hpapi-project-services/

Close in 10 seconds

Pharmaphorum.com

Search